chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dizzy; gum infection; vertigo; was not able to walk for about four hours after the shot; feeling so weak; body ache all over; swollen lymph nodes on the right side by the upper neck under her chin; Second dose 19 days after the first; high temperature for 2 days/light temperature for 3 to 4 days at least; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), GINGIVITIS (gum infection), VERTIGO (vertigo), GAIT DISTURBANCE (was not able to walk for about four hours after the shot) and ASTHENIA (feeling so weak) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM, FISH OIL and MAGNESIUM for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 19 days after the first). On an unknown date, the patient experienced DIZZINESS (dizzy), GINGIVITIS (gum infection), VERTIGO (vertigo), GAIT DISTURBANCE (was not able to walk for about four hours after the shot), ASTHENIA (feeling so weak), PAIN (body ache all over), LYMPHADENOPATHY (swollen lymph nodes on the right side by the upper neck under her chin) and PYREXIA (high temperature for 2 days/light temperature for 3 to 4 days at least). The patient was treated with PENICILLIN NOS (PENICILLIN [PENICILLIN NOS]) for Gum infection, at a dose of 500 mg. On 20-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 19 days after the first) had resolved. At the time of the report, DIZZINESS (dizzy), GINGIVITIS (gum infection), VERTIGO (vertigo), GAIT DISTURBANCE (was not able to walk for about four hours after the shot), ASTHENIA (feeling so weak), PAIN (body ache all over) and LYMPHADENOPATHY (swollen lymph nodes on the right side by the upper neck under her chin) outcome was unknown and PYREXIA (high temperature for 2 days/light temperature for 3 to 4 days at least) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) High body temperature for 2 days.         This case was linked to MOD-2021-325583 (Patient Link).
Blood in stool Saturday afternoon  Blood in Stool Sunday Morning  Cramps  Bad Headache Chills  Night sweats  Stomach Ache  Left Foot pain
Unexplainable fibromyalgia-type symptoms in previously healthy 28yo athlete. April/May - High blood pressure, insomnia, heart palpitations, excruciating pressure in chest/neck/base of skull, shortness of breath, generalized weakness, numbness/tingling in lower extremities, numbness/tingling in hands, burning pain in calves and feet, fatigue, brain fog June - heart palpitations, insomnia, pressure in chest/neck/base of skull (improved from May), shortness of breath, leg weakness, numbness/tingling in lower extremities, numbness/tingling in hands, numbness/tingling/burning/creeping crawling sensations in both legs, brain fog July to present  - heart palpitations, sleep disturbances, pressure in chest/neck/base of skull (improved from June), numbness/tingling in lower extremities,  numbness/tingling/burning/creeping crawling sensations in both legs, brain fog, poor short term memory,
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No information on patients' medical history, concurrent conditions and concomitant medications was provided. On an unknown dates, the patients were vaccinated with 11 improperly stored doses of PROQUAD (Merck) injection (dose, lot#, route of administration and expiration date were not reported). No adverse effects reported. This is one of the two reports from the same source. Additional information has been requested.
SECOND DOSE WAS ADMINISTERED ON 4/02/2022. THIRD DOSE OR BOOSTER ADMINISTERED TODAY WAS AN EARLY DOSE GIVEN 3 MONTHS EARLY.  PATIENT IS STABLE, NO SIDE EFFECTS REPORTED.
8 days after injection,  March 11, I had a reaction on my arm from the shot.  I have a large red rash on my left arm under where I got my shot.  It is itchy and sore.  It has been this way for 5 days now.  Today being the worse, 3/16/21.
Information has been received from a registered nurse concerning her daughter, an 18 year old female with no known pertinent medical history or drug reactions/allergies who on 22-AUG-2008 was vaccinated with a first dose of GARDASIL 0.5 ml IM. The patient developed a fever after receiving the first dose of GARDASIL. There was no concomitant medication. On 23-AUG-2007 the patient recovered from fever. On 25-OCT-2007 the patient was vaccinated with a second dose of GARDASIL 0.5 ml IM. On 26-FEB-2008 the patient was vaccinated with a third dose of GARDASIL 0.5 ml IM. It was noted that all doses were administered "in hip". The patient sought medical attention in the office at a later visit. Additional information has been requested. The patient's sister also had an adverse experiences with vaccination with GARDASIL (WAES# 0807USA01027).
about a quarter inch swollen/ my tongue is swollen; tongue feels thicker; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (about a quarter inch swollen/ my tongue is swollen) and TONGUE DISORDER (tongue feels thicker) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic bronchitis. Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY) for Chronic bronchitis.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Oct-2021, the patient experienced SWOLLEN TONGUE (about a quarter inch swollen/ my tongue is swollen) and TONGUE DISORDER (tongue feels thicker). At the time of the report, SWOLLEN TONGUE (about a quarter inch swollen/ my tongue is swollen) and TONGUE DISORDER (tongue feels thicker) outcome was unknown.            It was reported that the patient had completed the series of Moderna COVID-19 Vaccination in Feb-2021 and did not experienced this symptoms.  No treatment medications were reported.
Caller is an office manager who reports administration of vaccine following temperature excursion. No adverse effects of administration. No further information provided. No other AE/no PQC.         ?    Names of vaccines involved (including lot/exp; Caller is an office manager who reports administration of vaccine following temperature excursion. No adverse effects of administration. No further information provided. No other AE/no PQC.         ?    Names of vaccines involved (including lot/exp; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 18-APR-2022, the patient was vaccinated with an improper storage dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5ml/once, with valid lot #U016064, expiration date: 20-MAY-2023 (strength, route of administration, and indication were not provided); and with sterile diluent (DILUENT MRK) (strength, formulation, dose description, lot #, expiry date, route of administration, and indication were not provided).  Temperature was 14.5 degree Celsius (C) time frame of 10 hours, there was not previous temperature excursion. No adverse effects after administration. No further information was provided.
FOLLOWING SECOND DOSE, RAPID ONSET OF SEVERE PAIN IN LEFT ARM AND SHOULDER, PAIN OF NECK, UPPER BACK, RIGHT SHOULDER. THE FOLLOWING DAY, 01/31, FEVER VARYING FROM 101 TO 105 FOR FOUR DAYS. ABDOMINAL AND CHEST PAIN, RUNNY NOSE, HEADACHE AND MIGRAINE SYMPTOMS. DIAHRREA, NAUSEA AND VOMITING. LOOSE STOOLS PERSISTED FOR ELEVEN DAYS FOLLOWING INJECTION OF SECOND DOSE OF THE MODERNA 030L2OA. AFTER EVERY MEAL, UNDIGESTED STOMACH CONTENTS PASSED VIA RECTUM, WITH WATERY MUCOUS. LOSS OF APPETITE, GENERAL MALAISE. ON DAY 3, NEAR SYNCOPE COUPLED WITH HYPOTENSION AND HYPOGLYCEMIA WITH DEHYDRATION. CONSUMED 1L OF PEDIALYTE/DAY, WITH 2L OF WATER/DAY. COVID-19 RAPID TEST WAS NEGATIVE.
urticarial rash w/in few hr (no sure exact onset time) duration -2 days;tx-DPH;
Back pain; This is a spontaneous report from a contactable consumer (patient). A 78 year female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot: EN6198) at single dose Intramuscular in left arm on 06Mar2021 for Covid-19 immunization.  Medical history included autoimmune system hepatitis, High Blood Pressure, Lung Cancer in remission, colonoscopy that was done 5-6 years ago. She further stated that she had surgery in the past that messed up her liver and kidneys, her autoimmune system went wacky. She had diabetes previously, but no longer had that.  No family medical history relevant to the event. Concomitant drugs included ongoing metoprolol succinate ER 50mg tablet orally once daily for high blood pressure (patient had been taking 20 years as of 06Apr2021 if not longer), ongoing apixaban (ELIQUIS) 2.5mg tablet orally at 2.5 mg twice per day from an unknown date to an unknown date for about 4 or 5 years as of 06Apr2021 for blood clot, and 5 mg twice a day Mar2021 as she developing another blood clot while on the 2.5mg and raised the dose (AER 2021379982), ongoing azathioprine tablet 50 mg tabs orally once daily (been taking it about a year as of 06Apr2021), ongoing spironolactone 25mg tabs orally once daily from 2020, ongoing escitalopram 10 mg tablets orally once daily from an unknown date (reported as started in 2020 or a little bit longer ago), ongoing azathioprine (IMURAN) from 2017 at 50 mg tablets orally once daily for hepatic cirrhosis, and biotin, carbohydrates nos, fats nos, minerals nos, potassium, proteins nos, sodium, vitamins nos (BOOST) drinks for years. Patient stated one of her medications was to help calm her down, but she did not know which one. She confirmed she did not think she had ever had any other Pfizer vaccines. No additional Vaccines Administered on Same Date of the Pfizer Suspect.  No other vaccinations within four weeks prior to the first administration date of the suspect vaccine. She went to the hospital after her first Pfizer COVID-19 Immunization. She explained that she had previous surgery and she was having trouble with a colonoscopy that was done 5-6 years ago. She went in to have a mesh put in to take away the pain. It was further reported that she could not recall if the surgery to have mesh placed was before or after the first Pfizer COVID-19 vaccination. She later added she thinks she had the surgery on 02Mar2021, but she not sure. She called the doctor about pain in her back and telling the doctor she wasn't sure if it was pain from the surgery or pain from the recent Pfizer COVID-19 immunization. The doctor told him if it got any worse to go to the emergency room, but it got better. Patient stated that it got better and she did not go to the emergency room, and did not go to the hospital. All her tests have been good, no additional details provided. No Relevant Tests performed.  She had recovered from back pain.  The report was considered non- serious.      No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse and a mother concerning a 17 year old female patient with no pertinent medical history who in June 2003, was vaccinated with a second dose of hepatitis B virus vaccine P1: May 2003. There was no concomitant medication. The patient developed abdominal pain and was diagnosed with pancreatitis at the end of July 2003 by her family doctor. On 7/25/03 a chest x-ray and CT scan were performed. The CT scan showed a dilated common bile duct and mild pancreatitis. On 7/27/03 an abdominal ultrasound was done and the visualized portion of the pancreas and liver were unremarkable. The patient was hospitalized at her local hospital and then discharged to home. At this time, the family recommended that the patient schedule an appointment with the gastroenterologist for her abdominal pain and pancreatitis. The appointment was scheduled and prior to being seen by the gastroenterologist, the patient was hospitalized on 8/19/03. The nurse reported that the diagnosis of pancreatitis was determined by increased lab values and not x-rays. On 8/19/03 her amylase was 1812 and lipase was 2544. An ERCP (Endoscopic Retrograde Cholangiopancreatography) showed inflammation or obstruction. Stents were placed and a sphincterotomy was performed. The patient was discharged from the hospital on 8/21/03. She started feeling better, but when she was given her second ECRP test, she had a relapse. On 9/25/03, another ERCP was performed with stent placement and sphincterotomy. At a follow up visit the patient was treated with promethazine hydrochloride for mild nausea. The patient currently is being followed by a medical center. She continues to see the gastroenterologist for follow up and repeat lab tests. The nurse reported that the patient is improving and was given a note to return to school. It was also reported that blood tests were taken and she was recovering with sequelae. Additional information has been requested. As of 10/31/03, the nurse reported that "she was doing okay now." Additional info has been requested. Follow up info was received from a nurse at the doctor's office, in which she stated "the physicians are not thinking that the pt's problem was due to the (hep B virus vaccine vaccination." Additional info has been requested. Follow-up information was received from a nurse at the doctor's office, in which she stated "the physicians are not thinking that the patient's problem was due to the [hepatitis B virus vaccine rHBsAg (yeast) vaccination". Additional information has been requested.
Member complains of "severe itching" from head-to-toe. Member given Benadryl and Clartin by doctor.
low grade fever, loss of appetite, achy, dizziness, constipation lasted 3 days;
Patient reports vaginal discharge started 10 days after receiving 2nd dose of Moderna vaccine. Discharge dark in color, not blood, odorless and no pain. Saw GYN 2/24/21. Had pessary removed, cleaned and reinserted; Will f/u to GYN in 4 weeks
Swollen, erythematous area @ site of vax; pt recvd vax 5MAR92 & noted rxn next day, seen in clinic 10MAR92;
Side effects of very sore left arm body aches, chills, pain in neck and shoulders follow by tingling/numbness left face and lips
Pt was vaccinated on 8/26/13 on 8/28/13 pt mother called health dept stating pt was running fever and small nodule and redness noted where DTap was given. Instructed mom symptoms normal to administer fever reducer and apply cold pack to injection site. 8-30-13 mother called and stated child still has fever and now has a generalized rash. States it is red with small whiteheads, appears measle like. Informed mom to call PCP and make appt. Since child has had such a hard time. Rash could be normal as described or VIS.
I started with a high fever of 104.7 degrees and went to urgent to test for COVID test which was negative and they did a chest x-ray and they advised me to go to the hospital because there were lymph nodes showing up on my lungs. I was advised to go to the hospital and lymph nodes were found on my lung. They did 3 biopsies, PET scan, and CAT scan but couldn't determine the cause. I was given antibiotics to help with the high fever but it didn't respond so they gave me  steroids and they went away but I am under observations. There were suspicions of lymphoma but not confirmed. I am taking pain killers because the robotic biopsy caused nerve damage in my rib cage.
coughing; wheezing; Initial information was received on 17-Oct-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-healthcare professional.  This case involves a 66 years old female patient who experienced coughing and wheezing after receiving influenza vaccine, RSV vaccine and treprostinil sodium.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Pulmonary arterial hypertension.  Concomitant medications included Tadalafil.  On an unknown date in Apr-2021, the patient started taking treprostinil sodium at a dose of 0.05 ug/kg via intravenous not other specified (nos) (form, strength, frequency, lot number, expiration date: unknown) for Pulmonary arterial hypertension.  On 26-Sep-2023, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer and unknown dose of suspect RSV vaccine not produced by Sanofi Pasteur (unknown formulation) (lot number, expiry date, strength, was unknown) via unknown route in unknown administration site for Immunization. The information on the batch number was requested.  On an unknown date in Sep-2023 the patient had coughing (cough) and wheezing (unknown latency) following the administration of influenza vaccine, RSV vaccine and treprostinil sodium.  No action was taken with treprostinil sodium and action taken with influenza vaccine and RSV vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events (coughing, wheezing).  At time of reporting, the outcome was Unknown for the events.
allergies; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported that a female patient of an unspecified age received BNT162B2 via an unspecified route of administration on 01Mar2021 (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient was needed to take Zyrtec (antihistamine) for her allergies. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day of vaccination, patient experienced uncontrollable tremors in both arms. In response, patient took a dose of ibuprofen, performed stretches and took a nap; symptoms subsided. On June 28th, 2021, patient experienced another bout of tremors in both extremities at around 10am, which persisted for approximately 12 hours. After a televisit with CRNP, patient was referred to Emergency room. Patent reported to Hospital with continuing tremors. Doctors examined the patient's blood, as they head suspected rhabdomyolysis after ruling out any neurological causes for the symptoms. All bloodwork came back negative. Doctors intravenously injected 1.5 liters of saline fluid, after which the tremors subsided. Patient was thus discharged from ER. On July 2, 2021, at around 6pm, patient experienced sporadic tremors in right arm, which subsided after approximately 30 minutes. On July 4th, 2021, patient experienced frequent and sporadic tremors in both arms during the course of the day. Symptoms only subsided with sleep. On July 5th, 2021, patient experienced tremors in all four extremities during the course of the day. Consumed electrolyte water, remembering that the saline IV fluids had previously treated the tremors. Frequency and intensity of tremors decreased after patient consumed 48 fl oz of electrolyte water. Tremors fully subsided in sleep. On July 7th, 2021, patient was admitted to Family Practice and referred for a CT scan while still experiencing tremors. Scan showed no hemorrhages or growths in brain. Patient continues to experience sporadic and frequent tremors in all four extremities, varying in length and intensity.
Vertigo, mild, beginning 2-3 hours after vaccination, subsided after a few hours Tinnitus, beginning 8 days after vaccination.  Still present two weeks later.
Within 15-20 minutes of receiving the vaccine, my tongue started to feel thicker and stiffer. I did not have any other reaction - no hives/rash, no swelling of lips, no trouble breathing. I took Cetirizine and the symptoms improved within an hour.
Patient got pfizer dose 1,2 on 3/24 and 6/11.  Patient was not due for 3rd dose until 12/11 and got dose on 12/7. No adverse reactions so far
On 2/04/2007 Child received DTP #4 Polio #3 at Pediatrician's office- seen in our clinic today- Red rash, large welts torso & extemities & face- started with just red rash on 2/05/2007-
Covid injection might have been given to me aubcutaneously instead of IM.  Large area of induration, redness, swelling at injection site and surrounding area. This affected area appears to be possibly below the deltoid muscle region. The injection itself was not painful. This began the day after injection and has continued ever since. Today is day 8 of this reaction. I have pictures if needed. I have not seen anyone yet for this reaction. No result or outcome available as of now.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 8-week-old patient of unknown gender. On 03-JUL-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB lot number N031492 (expiration date 02-MAY-2020). This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
swelling, knot formation, discoloration of the area, inability to lift or sleep on arm.
Within 45 minutes my child started slurring his words, stuttering, drooling, and having issues focusing his mind and speech. He was also visibly disoriented(I watched him bumping into things he would not normally have bumped into). These were the only side effects, besides a sore injection site that he displayed. They lasted and faded over the
Symptoms: eyelids swelling/itching, nasal/sinus swelling, nasopharyngeal swelling, circumoral swelling-around mouth and lips, not inside mouth. Administered nasal Flonase 2 pumps each nare and 50 mg Benadryl at 2230. At 0430 next morning 12/29, swelling decreased, eyelids remained swollen and minimal swelling in nasal/sinus area. Continued Benadryl 50 mg every 6 hours x 3 doses, by 1900 on 12/29 swelling resolved